Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization

Published:2020-04 Issue: Volume:97 Page:103665
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Romagnoli Romeo,Prencipe Filippo,Oliva Paola,Kimatrai Salvador Maria,Brancale Andrea,Ferla Salvatore,Hamel Ernest,Viola Giampietro,Bortolozzi Roberta,Persoons Leentje,Balzarini Jan,Liekens Sandra,Schols Dominique

Funder

Life Sciences Research Network Wales

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference51 articles.

1. Microtubule organization, dynamics and functions in differentiated cells;Muroyama;Development,2017

2. A microtubule bestiary: structural diversity in tubulin polymers;Chaaban;Mol. Biol. Cell,2017

3. Microtubule targeting agents: a benchmark in cancer therapy;Nitika;Curr. Drug Ther.,2014

4. Tubulins-the target for anticancer therapy;Vindya;Curr. Top. Med. Chem.,2015

5. Taxane anticancer agents: a patent perspective;Ojima;Expert Opin. Ther. Pat.,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Profile of Synthetic and Natural Indole Derivatives: Paving New Paths in Cancer Treatment;Drugs and Drug Candidates;2024-07-19

2. Recent advances in the green synthesis of indole and its derivatives using microwave irradiation and the role of indole moiety in cancer;Green Chemistry Letters and Reviews;2024-07-16

3. Efficient assembly and anti-tumor evaluation of novel polycyclic [1,2-a]-fused indoles;Bioorganic Chemistry;2024-05

4. Systematic Photoassisted Access to Designer Polyheterocycles via Modular Blocks and Scaffolding;Organic Letters;2024-01-12

5. Development of tubulin polymerization inhibitors as anticancer agents;Expert Opinion on Therapeutic Patents;2023-11-02